[Federal Register Volume 72, Number 19 (Tuesday, January 30, 2007)]
[Notices]
[Pages 4276-4277]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-365]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5. 
U.S.C., as amended. The grant applications and/or contact proposals and 
the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications and/or 
contract proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, R25 Special Emphasis Panel.
    Date: February 6, 2007.
    Time: 5 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Washington Court Hotel, 525 New Jersey Ave, NW., 
Washington, DC 20001.
    Contact Person: David E. Maslow, PhD., Chief, Resources and 
Training Review Branch, Division of Extramural Activities, National 
Cancer Institute, National Institutes of Health, 6116 Executive 
Boulevard--Room 8117, Bethesda, MD 20892-7405, (301) 496-2330.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Arrays for Biomarker.
    Date: February 13, 2007.
    Time: 12 p.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Lalita D. Palekar, PhD, Scientific Review 
Administrator, Special Review and Resources Branch, Division of 
Extramural Activities, National Cancer Institute, National 
Institutes of Health, 6116 Executive Boulevard, Room 8105, Bethesda, 
MD 20892-7405, (301) 496-7575.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Multiplex Affinity Capture Technology.
    Date: February 15, 2007.
    Time: 12 p.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Lalita D. Palekar, PhD, Scientific Review 
Administrator, Special Review and Resources Branch, Division of 
Extramural Activities, National Cancer Institute, National 
Institutes of Health, 6116 Executive Boulevard, Room 8105, Bethesda, 
MD 20892-7405, (301) 496-7575.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Manpower and Training Grants.
    Date: February 27-28, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Old Town Alexandria, 1767 King Street, Alexandria, 
VA 22314.
    Contact Person: Lynn M Amende, PhD, Scientific Review 
Administrator, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Boulevard Room 8105, Bethesda, MD 20892-8328, 301-451-4759, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Small Grants Program for Cancer Epidemiology and Cancer 
Prevention Research.
    Date: March 6-8, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW., 
Washington, DC 20007.
    Contact Person: Irina Gordienko, PhD, Scientific Review 
Administrator, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Blvd., Rm. 703, MS 2829, Bethesda, MD 20892, 301-594-1566, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Anti-Cancer Agents.
    Date: March 15, 2007.
    Time: 11 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health Events Management, 
Executive Plaza North Conference Center, 6130 Executive Boulevard, 
Conference Room D, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Jeannette F Korczak, PhD, Scientific Review 
Administrator, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Blvd., Room 8115, Bethesda, MD 20892, 301-496-9767, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


[[Page 4277]]


    Dated: January 21, 2007.
David Clary,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-365 Filed 1-29-07; 8:45 am]
BILLING CODE 4140-01-M